Background/Aims: Emerging evidence suggests that autophagy plays important roles in the pathophysiological processes of cerebral ischemia and reperfusion injury. Calycosin, an isoflavone phytoestrogen, possesses neuroprotective effects in cerebral ischemia and reperfusion in rats. Here, we investigated the neuroprotective effects of calycosin against ischemia and reperfusion injury, as well as related probable mechanisms behind autophagy pathways. Methods: A cerebral ischemic and reperfusion injury model was established by middle cerebral artery occlusion in male Sprague-Dawley rats. Neurological scores, infarct volumes, and brain water content were assessed after 24 h reperfusion following 2 h ischemia. Additionally, the expression of the autophagy-related protein p62 and NBR1 (neighbor of BRCA1 gene 1), as well as Bcl-2, and TNF-α in rat brain tissues was measured by RT-PCR, western blotting and immunohistochemical analyses. Results: The results showed that calycosin pretreatment for 14 days markedly decreased infarct volume and brain edema, and ameliorated neurological scores in rats with focal cerebral ischemia and reperfusion. It was observed that levels of p62, NBR1 and Bcl-2 were greatly decreased, and levels of TNF-α significantly increased after ischemia and reperfusion injury. However, calycosin administration dramatically upregulated the expression of p62, NBR1 and Bcl-2, and downregulated the level of TNF-α. Conclusions: All data reveal that calycosin exerts a neuroprotective effect on cerebral ischemia and reperfusion injury, and the mechanisms maybe associated with its antiautophagic, anti-apoptotic and anti-inflammatory action.
Neuroprotective Mechanisms of Calycosin Against Focal Cerebral Ischemia and Reperfusion Injury in Rats
Yong
Introduction
Cerebral ischemia and reperfusion (I/R) injury is a complex of pathophysiological events linked to deprivaition of oxygen and energy from blood during the period of ischemia, eventually resulting in neuronal destruction [1, 2] . Pathogenic mechanisms following cerebral ischemia and reperfusion are associated with energy failure, elevation of the intracellular Ca 2+ level, release of excitatory neurotransmitters, oxidative stress, inflammation, apoptosis, etc. [3] . Recent data indicate that autophagy is activated in cerebral ischemia and performs a vital role in the mechanisms underlying I/R-induced neuronal damage [4, 5] . However, the relationship between autophagy and cerebral ischemia is far from clear.
Currently, there are two therapeutic strategies used in cerebral ischemia and reperfusion (I/R) injury. The most common is to restore blood flow by administering thrombolytic agents [6] . However, thrombolytic therapy can lead to hemorrhagic complications, and the strict 3-hour time therapeutic window is the main barrier. Neuroprotection, as another strategy for treatment of cerebral ischemia and reperfusion injury, has attracted much attention in recent years [7] .
Accumulating evidence has shown that phytoestrogens exert beneficial effects in a variety of neurodegenerative disorders, including acute ischemic stroke [8] [9] [10] Due to a structural similarity to the mammalian estrogen, phytoestrogens can selectively bind estrogen receptors (ERs) to regulate relevant gene expression and produce estrogenic and/or anti-estrogenic effects. Calycosin, as an isoflavone phytoestrogen isolated from Astragalus membranaceus, is found to possess various potential pharmacological activities. In previous studies, calycosin exerted anti-tumorigenesis, anti-oxidation, antivirus and apoptosis-modulation effects [11] [12] [13] [14] . Additionally, our preliminary data have shown that calycosin has neuroprotective effects in cerebral I/R in rats via downregulation of RASD1 (Dexamethasone-induced Rasrelated protein 1) and upregulation of miR-375 [15] . However, the further neuroprotective mechanisms of calycosin involved in autophagy and apoptosis needed to be investigated. Therefore, the current study aimed to discuss the molecular mechanisms of calycosin effects against cerebral I/R injury in rats.
Materials and Methods

Drugs
Calycosin (purity≥ 98.0%, obtained from Phytomarker Ltd, Tianjin, China) (Fig. 1A) was dissolved in dimethyl sulfoxide (DMSO) to make a 200 mM stock solution and stored at 4 °C for further use.
Animal experiments
Adult male Sprague-Dawley rats (220-250 g) were purchased from the Experimental Animal Center of Guilin Medical University. All rats were housed in a temperature-controlled (22-23°C) environment under a 12-h light/ 12-dark cycle with free access to food and water. Experiments were conducted in accordance with animal care guidelines approved by the Animal Ethics Committee of the Guilin Medical University. All animal studies were performed according to the National Institute of Health Guide for the Care and Use of Laboratory Animals.
A model of focal cerebral ischemia and reperfusion used in this study was established as previously reported with some modifications [16] . Briefly, rats were anesthetized with 10% chloral hydrate (350 mg/ kg, ip) 1 h after the last drug administration. The right common carotid artery and external carotid artery were exposed. A nylon filament with a silicon coated tip was inserted into the external carotid artery and advanced into the internal carotid artery until it blocked the origin of the middle cerebral artery (MCA), at which mild resistance was felt. During the surgery, the rectal temperature was maintained at 37-38 °C with a heating pad. After ischemia for 2 h, the filament was gently removed, and animals were allowed to recover. For the sham-operated group, rats underwent the same surgical procedures, but without occlusion of the external carotid artery.
In this study, the experimental rats were randomly assigned to different groups (n=10): sham-operated group; I/R group; and calycosin-treated groups with different doses (intraperitoneal injection with calycosin 5, 10, 20 mg/kg/d for 14 days). Neurological deficit scoring and infarct volume measurement After 2 h ischemia followed by 24 h reperfusion, the neurological deficit was evaluated according to the 5-point scoring system described by Longa et al [16] .. Briefly, rats with a normal walk or no neurologic deficits were scored as 0, with a failure to extend the opposite forepaw fully or with a mild focal neurologic deficit scored as 1, with circling to the contralateral side or with a moderate focal neurologic deficit scored as 2, with falling to the contralateral side or with a severe focal neurologic deficit scored as 3, and with no spontaneous walking and a depressed consciousness level scored as 4. Neurological deficit scoring was performed by an investigator who was blinded to animal treatments.
After 24 h of reperfusion, the brains were immediately removed and sliced into coronal sections at 2 mm intervals with brain-cutting matrix. The slices were incubated in 2% 2, 3,5-triphenyltetrazolium chloride (TTC) solution for 30 min at 37 °C. The stained brain slices were photographed with a digital camera. Relative lesion volumes were calculated as the ratio of non TTC stained areas (white, infarct area) to total area, and expressed as a percentage. Image analysis software (NIH Image, National Institutes of Health, Bethesda, Version 1.63) was used to for measurement of the infracted area.
Measurement of the brain edema
The extent of cerebral edema was evaluated by measuring brain water content according to the wetdry method. In brief, brains were quickly removed and weighed to obtain the wet weight using an electronic analytic balance. Then, the samples were dried in an oven at 100 °C for 24 h and weighed again to obtain the dry weight. The degree of brain water content was calculated as follows: water content = (wet weight − dry weight) / wet weight ×100%.
Immunohistochemical analyses
At 24 h after reperfusion, rats were deeply anesthetized and perfused transcardially with normal saline, followed by 4% PFA (paraformaldehyde) in PBS (phosphate buffered solution). The brains were harvested and fixed in 4% PFA for 24h. A standard paraffin block was prepared, and a series of 5 μm thick sections were cut. After being dewaxed and rehydrated, sections were incubated with primary antibodies (1:500; Abcam, Cambridge, MA, USA) at 37 °C overnight. Sections were rinsed three times with PBS, and the sections were incubated with corresponding secondary antibodies (1:500; ZSGB-BIO, Beijing, China) for 1 h at 37 °C in a humidified chamber in the dark. Samples were subsequently stained with DAB (diaminobenzidine) and hematoxylin. The sections were digitized and analyzed under an optical microscope. Brown particles observed via optical microscopy in the cytoplasm or nucleus indicated positively stained cells. Five fields of view were randomly selected at 200× magnification for analyzing the integral optical density (IOD) value, using Image-Pro Plus 6.0.
Quantitative real RT-PCR
Total RNA was extracted from the ischemic penumbras of rat brains with Trizol reagent (Invitrogen, New York, USA), and reverse-transcription reactions were performed using the First Strand cDNA Synthesis Kit (TIANGEN, Beijing, China) according to the manufacturer's instructions. Target gene expressions (rat Bcl-2, NBR1, p62, TNF-α) were measured by quantitative real-time PCR using the ABI PRISM 7500 Sequence Detector System (Applied Biosystems, Carlsbad, CA, USA). The 2 -ΔΔCT method was used to calculate the relative levels of gene expression. Transcriptional levels were normalized to β-actin in all samples.
Western blotting test
Rat brain tissues of the ischemic penumbras were separated and homogenized with RIPA lysis buffer (Beyotime, Nanjing, Jiangsu, China). The lysates were centrifuged at 12, 000 rpm for 10 min at 4°C. The supernatant protein concentration was measured with a BCA (bicinchoninic acid) protein assay kit (Beyotime, Nanjing, Jiangsu, China). Then, sodium dodecyl sulfate (SDS) sample loading buffer was added to the supernatant, and the mixture was boiled at 100 °C for 5 min. Samples containing 40 µg protein per lane were separated using SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) and transferred to PVDF (polyvinylidene fluoride) membranes (Millipore, Bedford, MA, USA). Blots were blocked with TBST (tris buffered saline with Tween 20) containing 5% nonfat dried milk for 1 h. Following blocking, the membranes were incubated overnight at 4 °C with the following primary antibodies: Bcl-2, NBR1 (neighbor of BRCA1 gene 1), p62, TNF-α (Santa Cruz, Dallas, Texas, USA; 1:1000), and mouse anti-rat Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry β-actin antibody (1:500; ZSGB-BIO, Beijing, China; 1:2000). After three washes in TBST, the membranes were subsequently incubated with the appropriate secondary antibodies coupled to horseradish peroxidase at room temperature for 1 h. Protein bands was scanned and visualized using an enhanced chemiluminescence detection system (Life Technologies, Pleasanton, CA, USA). The optical density of the bands was quantified with a computer-assisted image analysis system (Bio-Rad Laboratories, Hercules, CA, USA) and normalized to β-actin protein level.
Statistical analysis
All data were expressed as the mean ± Standard Error (S.E.). The Statistical Package for Social Sciences (SPSS) 13.0 software (SPSS, Chicago, IL) was used for statistical analyses, including a one-way ANOVA and Student's t-test. A probability (p)-value ＜0.05 was considered statistically significant.
Results
Treatment of calycosin attenuated I/R-induced neurological impairments and decreased the ischemic infarct area and brain edema
To determine whether calycosin treatment led to an improvement in neurological function after ischemia, neurological deficit scoring was carried out. As shown in Fig. 1B , rats in the sham-operated group presented no neurologic deficits, while obvious neurological deficits were observed in the I/R group, suggesting that the MCAO model was successfully constructed. Additionally, 5-20 mg/kg of calycosin reduced the neurological deficit scores in a dose-dependent manner, indicating that calycosin ameliorated the brain dysfunction.
In rats subjected to MCA occlusion for 2 h followed by 24 h reperfusion, an increase in the infarct area and brain edema was also observed. As shown in Fig. 1C and 1D , the infarct size and brain water content in the I/R group obviously increased compared to that in the shamoperated group, while calycosin significantly decreased the infarct size and brain water content dosedependently. These results suggest that calycosin alleviated the damage in the ischemic brain areas.
Calycosin increased p62 and NBR1 expression in cerebral ischemia and reperfusion rats
It has been demonstrated that p62 and NBR1 are substrates for selective △△ P < 0.01, I/R vs the Sham group; *P < 0.05, **P < 0.01, vs the I/R group, n =8. autophagy. The mRNA and protein levels of the above two molecules related to autophagy were examined in I/R injury brain tissue. As Fig. 2A-B and Fig. 3A-B illustrate, the relative expression of both p62 and NBR1 was significantly downregulated in the I/R group, and calycosin significantly increased the expression of the two molecules in a dose-dependent manner. Meanwhile, immunohistochemical analyses showed that the number of p62 and NBR1 positive cells in calycosin-treated I/R rat brains were also increased in comparison to those in the I/R group (Fig. 2C and Fig. 3C ). The results indicate that calycosin may achieve a neuroprotective effect via inhibition of the autophagy activated by I/R injury. △△ P < 0.01, I/R vs the Sham group; *P < 0.05, **P < 0.01, vs the I/R group, n =3. 
Calycosin increased Bcl-2 expression in cerebral ischemia and reperfusion rats
To investigate calycosin-triggered anti-apoptosis, we examined mRNA and proteins expression of Bcl-2. As shown in Fig. 4A -B, RT-PCR and western blot results suggested that less Bcl-2 mRNA and protein were observed in the I/R group compared with those in the shamoperated group (P＜0.05), while mRNA and protein levels of Bcl-2 were gradually increased △△ P < 0.01, I/R vs the Sham group; *P < 0.05, **P < 0.01, vs the I/R group, n =3. (Fig. 4C) . Based on the above results, calycosin exhibited antiapoptotic effects during the process of I/R brain injury.
Calycosin inhibited TNF-α expression in cerebral ischemia and reperfusion rats
To further analyze calycosin-induced anti-inflammatory effects, we examined mRNA and protein expression levels of TNF-α. As shown in Fig. 5A-B , levels of TNF-α were significantly elevated in the I/R group compared with those in the sham-operated group (P＜0.01). Treatments with calycosin markedly attenuated the increase of TNF-α in a dose-dependent manner (P＜0.01 or P＜0.05). In accordance with the mRNA and protein expression results, immunohistochemistry analyses also showed that TNF-α positive cells gradually reduced in number following calycosin treatment (Fig. 5C ). These results indicate that calycosin may produce neuroprotection by suppressing neuroinflammation in cerebral I/R rats.
Discussion
It is generally accepted that neuroprotective therapy is an effective strategy to reduce neuronal damage during the process of cerebral I/R. However, experimental searches for neuroprotective agents and their mechanisms have so far failed to reveal effective agents. Accumulating evidence indicates that estrogens and estrogen-like compounds are powerful agents to protect neurons from neuropathological and neurotoxic challenges and promote their survival [17] [18] [19] . In the present study, calycosin, a typical isoflavone phytoestrogen, markedly improved neurological deficits and reduced both infarct size and brain edema. Moreover, administration of calycosin increased the expression of p62, NBR1 and Bcl-2, and reduced the expression of TNF-α. Collectively, these data suggest that calycosin provides neuroprotection for cerebral I/R rats via key molecules involved in autophagy, apoptosis and inflammation.
Previous studies have identified at least three pathways of cell death in ischemic brain injury, including necrosis, apoptosis and autophagy [20] . Cerebral I/R injury could initiate physiopathologic cascades of cell death signaling and induce multiple cell death modes. In recent years, scholars have confirmed that autophagy can be induced in brain tissues or neuronal cells after ischemic stimulation [4, 21] . Autophagy is a conserved degradation pathway that delivers cytoplasmic proteins or damaged organelles to lysosome during stress conditions. P62 (also known as sequestosome-1/ SQSTM1) is a selective substrate of autophagy and a multidomain scaffold protein [22] . Due to the presence of the LC3-interacting region (LIR) and a C-terminal ubiquitin associated (UBA) domain, p62 can interact with LC3 (a mammalian homologue of Atg8) and bind to mono-or poly-ubiquitin. Therefore, p62 is considered to act as a receptor for ubiquitinated cargos, including ubiquitin-tagged proteins and whole organelles to be selectively degraded. Similar to p62, NBR1 also contains a LIR and a C-terminal UBA domain and can mediate the degradation of ubiquitinated cargos through their interaction with ubiquitin [23] . Since p62 and NBR1 are helpful in scaffolding misfolded or mutated proteins to form aggregates, and ultimately autophagic degradation, they may be used as markers to study autophagic flux. Recent data proposed that decreased levels of p62 can be observed when autophagy is induced and that p62 accumulates when autophagy is inhibited [24, 25] . Angeles Duran et al. found that p62 can suppress autophagy via activation of mTORC1 [26] . In addition, p62 is an important adaptor protein for several signaling pathways that regulate apoptosis, stress responses, inflammatory processes, and cell growth by interaction with a large number of proteins, including caspase-8, Keap1, Nrf2, TRAF6, NF-κB, etc. [27, 28] . Our results showed that calycosin leads to activation of p62 and NBR1, suggesting that calycosin inhibits autophagy and thus contributes its cerebral protective effect. The possible anti-autophagy mechanisms of calycosin may be related to Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry increasing the levels of p62 and NBR1, and thereby regulating misfolded or mutated proteins to ubiquitination and degradation during I/R injury. Apoptosis has been implicated in cerebral ischemic injury. Bcl-2, as a principal member of the Bcl-2 family that regulates apoptosis, is specifically regarded as an anti-apoptotic protein.
Bcl-2 plays an important role in promoting cellular survival and inhibiting the actions of proapoptotic proteins. Recent studies showed that there exists an intricate crosstalk between apoptosis and autophagy [29] . According to a previous study by Levine et al., Bcl-2 inhibits Beclin-1-dependent autophagy, thereby functioning both as pro-survival and anti-autophagy factors [30] . The present results demonstrate that the neuroprotective effects of calycosin might associate with an attenuation of ischemia-induced apoptosis through upregulation of the level of Bcl-2.
Inflammatory responses are considered to be the key element in the pathological progression of cerebral ischemia and reperfusion [31] . Following ischemic stress, damaged brain tissue secretes cytokines and chemokines that recruit inflammatory cells to the injured area. As one of the early initiators of inflammation after stroke, TNFα mediates apoptosis signals via the FADD (Fas associated death domain) of TNF-R1, and inflammatory responses via NF-χB [32] . Apart from apoptosis and autophagy, p62 is also involved in the regulation of NF-κB signaling pathways. Wooten MW et al. reported that p62 is needed for NF-χB-mediated neuronal survival and differentiation in response to NGF (nerve growth factor) [33] . Our results showed that the inhibitory effect of calycosin on the pro-inflammatory cytokine TNFα may be one of the crucial mechanisms in its effects against cerebral I/R injury. Additionally, reducing the levels of inflammatory mediators such as TNFα is the probable basis for ameliorating brain edema with treatment of calycosin.
In general, these findings suggest that cerebral I/R injury coincides with pathology associated changes in autophagy, apoptosis and inflammatory responses. The influence of the phytoestrogen calycosin on cerebral I/R injury is of practical importance for a variety of neurologic dysfunctions, in particular ischemic stroke. However, a limitation of this study should be noted: we did not determine the specific signaling pathways of calycosin in autophagy, apoptosis and inflammation regulation. A greater understanding of the neuroprotective molecular mechanisms of calycosin is needed by further study.
Conclusion
Taken together with our findings, the phytoestrogen calycosin significantly protected against cerebral ischemia and reperfusion injury in rats. The mechanism by which calycosin exerts its neuroprotective activity, at least partly, is its association with inhibiting the processes of autophagy, apoptosis and inflammation in the I/R-injured brain. These results suggest that calycosin can be further developed as a clinical neuroprotective candidate for treatment of ischemic stroke.
